Applied DNA Sciences Inc (APDN): "Under the terms of the Agreement, a $5...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Applied DNA Sciences Inc (APDN)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	13
Posts	2189
Boards Moderated	0
Alias Born	08/18/2012

Re: Parkmart post# 55607

Wednesday, 04/17/2019 10:53:20 PM

Wednesday, April 17, 2019 10:53:20 PM

"Under the terms of the Agreement, a $5 million up-front licensing fee is payable to Applied DNA over a four-month period beginning on or before April 15, 2019, and completed by October 15, 2019."

http://ih.advfn.com/stock-market/NASDAQ/applied-dna-sciences-inc-APDN/stock-news/79580132/applied-dna-announces-exclusive-cannabis-licensing

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent APDN News

Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/04/2024 10:18:33 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/12/2024 09:25:36 PM
Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/12/2024 09:09:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:05:22 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/08/2024 09:01:31 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/01/2024 09:05:28 PM
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:24:06 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/10/2024 10:16:03 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:00:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:05:23 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/07/2023 09:01:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 09:05:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 10:09:34 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/07/2023 10:02:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 08:05:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:05:45 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:01:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 08:02:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 09:04:44 PM
Applied DNA to Report Second Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, May 11, 2023 • Business Wire • 05/03/2023 07:00:00 PM

More APDN News

InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow